FDA 3.0 NAMs replacing animals Microfluidic Precision control ISTAND Program validated Pharma Adoption accelerating Multi-organ Systemic models Human-relevant Predictive data FDA 3.0 NAMs replacing animals Microfluidic Precision control ISTAND Program validated Pharma Adoption accelerating Multi-organ Systemic models Human-relevant Predictive data
Next-Gen Drug Testing

Cell-On-Chip Revolution

Cell-on-chip technology brings pharmaceutical research into a new era. Human cells in physiologically relevant microenvironments generate predictive data that animal models simply cannot provide.

Acquire Domain Explore Platform
CELL-ON-CHIP
$1.5B
Market by 2030
87%
Prediction Accuracy
35%
CAGR Growth
50+
Pharma Partners

Cell-On-Chip Capabilities

Human biology at your fingertips

🔬

Primary Human Cells

Work with patient-derived cells, iPSCs, and primary tissues. True human biology, not immortalized cell lines.

🧬

Dynamic Culture

Continuous perfusion delivers nutrients and removes waste. Cells experience in vivo-like conditions, not static wells.

📈

Real-Time Readouts

Integrated sensors measure barrier integrity, metabolites, and cell health. Live data, not endpoint assays.

🎯

Disease Modeling

Recreate patient pathology on-chip. Inflammatory, fibrotic, and infectious disease states for target validation.

⚙

ADME-Tox

Absorption, distribution, metabolism, excretion, and toxicity on one platform. Predict human PK/PD before clinical trials.

💡

Regulatory Ready

IND-enabling data accepted by FDA. Qualification through ISTAND and other programs accelerating adoption.

Own the Cell-On-Chip Brand

CellOnChip.com - Premium domain for microphysiological systems. Ideal for platforms, research, or commercial applications.

Contact for Pricing
Acquire This Domain

Own Cellonchip

This premium domain is available for acquisition. Perfect for companies, startups, or investors in this space.

Submit your inquiry below and we'll respond within 24 hours.